Antidepressant drug use and off-label prescribing in children and adolescents in Germany: Results from a large population-based cohort study

European Child and Adolescent Psychiatry

Volumn 22, Issue 8, 2013, Pages 511-518

  Dörks, Michael ^a   Langner, Ingo ^a   Dittmann, Ulrich ^a   Timmer, Antje ^a   Garbe, Edeltraut ^a  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

Author keywords

Antidepressants; Children; German Pharmacoepidemiological Research Database; Off label use; Pharmacoepidemiology; Prevalence

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HERBACEOUS AGENT; IMIPRAMINE; MIRTAZAPINE; MOCLOBEMIDE; OPIPRAMOL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG INDICATION; FEMALE; GENERAL PRACTITIONER; GERMANY; HIGH RISK PATIENT; HOSPITAL CARE; HUMAN; HYPERICUM PERFORATUM; HYPERKINESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL SPECIALIST; NEWBORN; OFF LABEL DRUG USE; POPULATION RESEARCH; POPULATION SIZE; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DEPRESSIVE DISORDER; FEMALE; GERMANY; HUMANS; MALE; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 84881480987     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-013-0395-9     Document Type: Article

References (27)

1. EMA: The European paediatric initiative: History of the Paediatric Regulation; 2007. Doc. Ref: EMEA/17967/04 Rev 1. http://www.ema.europa.eu/docs/ en-GB/document-library/Other/2009/09/WC500003693.pdf. Accessed: 25.05.2012
2. Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC (2006) Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J Clin Psychiatry 67(6):972-982
3. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197-206
4. Clavenna A, Bonati M (2012) Antidepressant prescriptions in paediatric outpatients in Europe. Paediatr Perinat Drug Ther 2007 8(3):103-108
5. Bucheler R, Meisner C, Kalchthaler B, Mohr H, Schroder H, Morike K, Schwoerer P, Schwab M, Gleiter CH (2002) "Off-label" prescribing of drugs in the ambulatory care of children and adolescents. Dtsch Med Wochenschr 127:2551-2557
6. Hoffmann F, Glaeske G, Petermann F, Bachmann CJ (2012) Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data. Pharmacoepidemiol Drug Saf 21(9):972-979. doi: 10.1002/pds.3295. Epub 2012 May 28
7. Pigeot I, Ahrens W (2008) Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 17:215-223
8. EMA: Note For Guidance On Clinical Investigation Of Medicinal Products In The Paediatric Population; 2001. CPMP/ICH/2711/99. http://www.ema.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2009/09/WC500002926.pdf. Accessed: 25.05.2012
9. Daly LE (1998) Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 147:783-790
10. Volkers AC, Heerdink ER, van Dijk L (2007) Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiol Drug Saf 16:1054-1062
11. Zito JM, Tobi H, de Jong-van den Berg LT, Fegert JM, Safer DJ, Janhsen K, Hansen DG, Gardner JF, Glaeske G (2006) Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiol Drug Saf 15:793-798
12. National Institute for Health and Clinical Excellence: depression in children and young people; identification and management in primary, community and secondary care 2005. http://www.nice.org.uk/nicemedia/pdf/ CG028NICEguideline.pdf. Accessed: 25.05.2012
13. American Academy of Child and Adolescent Psychiatry (2007) Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46(11):1503-1526
14. Ufer M, Meyer SA, Junge O, Selke G, Volz HP, Hedderich J, Gleiter CH (2007) Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 16:1153-1160
15. Murray ML, de Vries CS, Wong IC (2004) A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 89:1098-1102
16. Dt.Ges.f. Kinder- und Jugendpsychiatrie und Psychotherapie u.a. (Hrsg.): Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Deutscher Ärzte Verlag, 3. überarbeitete Auflage 2007 - ISBN: 978-3-7691-0492-9, S. 57-71
17. van Esso D, Del Torso S, Hadjipanayis A, Biver A, Jaeger-Roman E, Wettergren B, Nicholson A (2010) Paediatric primary care in Europe: variation between countries. Arch Dis Child 95:791-795
18. Kölch M, Prestel A, Singer H, Keller F, Fegert JM, Schlack R, Hoelling H, Knopf H (2009) Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol 19:765-770
19. Butler RJ, Heron J (2008) The prevalence of infrequent bedwetting and nocturnal enuresis in childhood. A large British cohort. Scand J Urol Nephrol 42:257-264
20. European Medicines Agency Press Release: European Medicines Agency finalises review of antidepressants in children and adolescents. 2005. http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/SSRI-31/ WC500013082.pdf. Accessed: 06.11.2012
21. Bundesinstitut für Arzneimittel und Medizinprodukte: Antidepressiva: Wissenschaftliche Neubewertung der SSRI/SNRI abgeschlossen - Neue Warnhinweise auf suizidales Verhalten bei Kindern und Jugendlichen. 2005. http://www.bfarm.de/DE/Pharmakovigilanz/risikoinfo/2005/RI-antidepressiva- neubewertung.html. Accessed: 06.11.2012
22. Bundesinstitut für Arzneimittel und Medizinprodukte BfArM. Zusätzliche Warnhinweise zum suizidalen Risiko bei Kindern und Jugendlichen für Ihre Arzneimittel aus der Gruppe der tricyclischen Antidepressiva (TCA). 2005. http://www.bfarm.de/SharedDocs/1-Downloads/DE/Pharmakovigilanz/am- sicher-akt/TCA-Schreiben050826.pdf?-blob=publicationFile. Accessed: 06.11.2012
23. Schirm E, Tobi H, de Jong-van den Berg LT (2003) Risk factors for unlicensed and off-label drug use in children outside the hospital. Pediatrics 111:291-295
24. Dittmann RW, Linden M, Osterheider M, Schaaf B, Ohnmacht U, Weber HJ (1997) Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine. Pharmacopsychiatry 30:28-34
25. Lee E, Teschemaker AR, Johann-Liang R, Bazemore G, Yoon M, Shim KS, Daniel M, Pittman J, Wutoh AK (2012) Off-label prescribing patterns of antidepressants in children and adolescents. Pharmacoepidemiol Drug Saf 21(2):137-144. doi: 10.1002/pds.2145. Epub 2011 Apr 28
26. Schink T, Garbe E (2010) Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database. 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) 19-22 August 2010, Brighton, England. Abstract published in: Pharmacoepidemiology and drug safety 19(Suppl 1):695
27. Schink T, Garbe E (2010) Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database. 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 19-22 August 2010, Brighton, England. Abstract published in: Pharmacoepidemiology and Drug Safety. 19(Suppl 1):420